Akero Therapeutics Company

Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).

Investors

Connections from

Technology: Biotechnology
Industry: Biotechnology
Founded Date: 2017.0
Employee Number: 56
Headquarters: United States
Register and Claim Ownership